Nitric oxide and endothelin in the development of cardiac allograft vasculopathy. Potential targets for therapeutic interventions (Q77227013)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

review article

1 reference

title

Nitric oxide and endothelin in the development of cardiac allograft vasculopathy. Potential targets for therapeutic interventions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

Z Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

S M Wildhirt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

S Weismüller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

C Schulze

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

N Conrad

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

B Reichart

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

1-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

Angiographic implications of cardiac transplantation

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Cardiac allograft vasculopathy: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Histological and immunohistochemical characteristics of eccentric coronary artery lesions retrieved by atherectomy from cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

The Role of Endothelium in Cardiovascular Homeostasis and Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Endothelin in Coronary Endothelial Dysfunction and Early Atherosclerosis in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Cloning and characterization of inducible nitric oxide synthase from mouse macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Control of coronary vascular tone by nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Nitric oxide synthases: Roles, tolls, and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Cyclic GMP and mechanisms of vasodilation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Nitric oxide: a physiologic messenger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Role of endothelium-derived nitric oxide in the regulation of blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

The discovery of nitric oxide in the vessel wall. A unifying concept in the pathogenesis of sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Control of regional blood flow by endothelium-derived nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Immunocytochemical localization of endothelin in cultured bovine endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Endothelin-3 is a novel neuropeptide: isolation and sequence determination of endothelin-1 and endothelin-3 in porcine brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Cloning and expression of a cDNA encoding an endothelin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Termination of endothelin signaling: role of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

The vascular biology of nitric oxide and its role in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Endothelium-derived nitric oxide, endothelin, and platelet vessel wall interaction: alterations in hypercholesterolemia and atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Nitric oxide synthase inhibition and platelet function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Nitric oxide and its role in the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Cell adhesion molecules in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Influence of endothelium-derived relaxing factor on platelet function and hemostasis in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

An L-arginine/nitric oxide pathway present in human platelets regulates aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Modulation of human platelet adenylate cyclase by prostacyclin (PGX)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Synergistic disaggregation of platelets by tissue-type plasminogen activator, prostaglandin E1, and nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Endothelium-derived relaxing factor and coronary vasospasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Nitric oxide: an endogenous modulator of leukocyte adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/C 3T3 fibroblasts by a cyclic GMP-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

L-arginine inhibits neointimal formation following balloon injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Hypercholesterolemia exacerbates transplant arteriosclerosis via increased neointimal smooth muscle cell accumulation: studies in apolipoprotein E knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Hypercholesterolemia causes generalized impairment of endothelium-dependent relaxation to aggregating platelets in porcine arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Attenuation of acetylcholine-induced vasoconstriction by L-arginine is related to the progression of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Non-invasive detection of early endothelial dysfunction in hypercholesterolaemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Inhibition of inducible nitric oxide synthase prevents myocardial and systemic vascular barrier dysfunction during early cardiac allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Dual effects of oxidized low-density lipoprotein on immune-stimulated nitric oxide and prostaglandin release in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Oxidized low density lipoproteins alter macrophage lipid uptake, apoptosis, viability and nitric oxide synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Megakaryocytes from patients with coronary atherosclerosis express the inducible nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Evidence for induction of nonendothelial NO synthase in aortas of cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Balloon injury and interleukin-1 beta induce nitric oxide synthase activity in rat carotid arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Evidence that expression of inducible nitric oxide synthase in response to endotoxin is augmented in atherosclerotic rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Increased plasma immunoreactive endothelin-1 concentration in hypercholesterolemic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Serum platelet-derived growth factor and endothelin concentrations in human hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Effect of endothelin on normal and diseased human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Endothelin inhibits presynaptic adrenergic neurotransmission in rat mesenteric artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Vascular responses to endothelin-1 in atherosclerotic primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Molecular biology and biochemistry of the endothelins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Arginine: a new therapy for atherosclerosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Biochemical mechanism of organic nitrate action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Biochemistry of Nitric Oxide and Its Redox-Activated Forms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Platelets, vasoconstriction, and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Endothelin at Pathophysiological Concentrations Mediates Coronary Vasoconstriction via the Endothelin-A Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Blocked ETA receptors prevent ischemia and reperfusion injury in rat lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Role of endothelin during reperfusion after ischemia in isolated perfused rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Antioxidant defenses and lipid peroxidation in human blood plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Probucol inhibits oxidative modification of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Restenosis revisited--new targets, new therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

L-arginine inhibits balloon catheter-induced intimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Characterization of the stable L-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as an NG-hydroxyl-L-arginine-nitric oxide adduct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Genetic models of human vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

Cellular signaling by peptides of the endothelin gene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Antiaggregatory and hypotensive effects of endothelin-1 in beagle dogs: role for prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Endothelial function. General considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900106-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(98)00106-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9733210%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference